December 1993
Volume 34, Issue 13
Free
Articles  |   December 1993
Concanavalin A-induced posterior subcapsular cataract: a new model of cataractogenesis.
Author Affiliations
  • A Gwon
    Allergan Pharmaceuticals, Irvine, California 92713-9534.
  • C Mantras
    Allergan Pharmaceuticals, Irvine, California 92713-9534.
  • L Gruber
    Allergan Pharmaceuticals, Irvine, California 92713-9534.
  • C Cunanan
    Allergan Pharmaceuticals, Irvine, California 92713-9534.
Investigative Ophthalmology & Visual Science December 1993, Vol.34, 3483-3488. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A Gwon, C Mantras, L Gruber, C Cunanan; Concanavalin A-induced posterior subcapsular cataract: a new model of cataractogenesis.. Invest. Ophthalmol. Vis. Sci. 1993;34(13):3483-3488.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

PURPOSE: To evaluate the effect of Concanavalin A (Con A) on cataract formation in New Zealand Albino rabbits. Uveitis is a chronic inflammatory condition of the eye involving the anterior and/or posterior segments. It may be acute or chronic and is associated with the development of posterior subscapular cataract over time. Con A is a nonspecific inflammatory agent and mitogen for T cells and some B cells. Used extensively in immunogenic studies Con A has been shown to induce uveitis after intravitreal injection in New Zealand Albino rabbits. METHODS: In two separate studies, Con A was injected intracamerally or intravitreally into one eye of 12 New Zealand Albino rabbits and an equal volume of balanced salt solution was injected into the opposite eye as a control. In a third study, the effect of topical steroids after intravitreal injection of Con A was evaluated. In all studies, anterior and posterior inflammation and the development of cataract was monitored by slit lamp biomicroscopy and photography. Cataract formation was also studied histopathologically. RESULTS: Initially, all eyes treated with Con A demonstrated moderate anterior chamber inflammation while eyes treated with balanced salt solution showed no inflammation. Three months after treatment, posterior subcapsular cataracts were present in all rabbit eyes treated with intravitreal Con A. In the third study, topical steroid treatment of Con A-induced inflammation significantly reduced anterior chamber inflammation but had no effect on vitreous humor and posterior subcapsular cataract formation. CONCLUSION: This experimental model was the first to demonstrate the development of posterior subcapsular cataracts after Con-A induced inflammation. The cataract was clinically and histologically similar to human posterior subscapular cataracts.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×